Acton, MA, United States of America

Yu Gui Gu

This inventor holds 11 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: Cubist Pharmaceuticals, Incorporated, Cubist Pharmacueticals, Inc.. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Gui Gu. Retrieved from https://idiyas.com/inventor/yu-gui-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 90.9

 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Yu Gui Gu - Pioneering Innovations in Acton

Introduction: Yu Gui Gu is a distinguished inventor based in Acton, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yu Gui Gu holds several patents in the areas of artificial intelligence, renewable energy, and advanced materials, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Yu Gui Gu has worked with leading research institutions and technology companies, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout his career, Yu Gui Gu has collaborated with top engineers, scientists, and researchers, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Yu Gui Gu's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Acton and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…